KinesioTaping for Thoracic Drain Support

NCT ID: NCT07098962

Last Updated: 2025-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-15

Study Completion Date

2025-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates the effectiveness of KinesioTaping applied around mediastinal and thoracic drain sites in reducing postoperative pain after cardiac surgery. Effective pain management is critical for early mobilization, improved patient satisfaction, and prevention of respiratory complications such as atelectasis. KinesioTaping is theorized to support soft tissue healing, improve circulation, and modulate pain through stimulation of cutaneous mechanoreceptors and fascia adjustment. However, evidence on its efficacy in postoperative settings remains limited. This prospective, randomized controlled trial aims to provide high-quality data on the role of KinesioTaping as a non-pharmacological adjunct for pain management in patients undergoing cardiac surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Postoperative pain following cardiac surgery is a significant clinical concern that can hinder early mobilization, reduce patient satisfaction, prolong hospital stay, and increase the risk of respiratory complications such as atelectasis and pneumonia. While pharmacological analgesia remains the mainstay of treatment, non-pharmacological adjuncts are increasingly being explored to enhance pain control and reduce reliance on opioids.

KinesioTaping (KT), a method originally developed for musculoskeletal conditions, involves the application of elastic therapeutic tape to the skin with the aim of supporting soft tissue structures, enhancing lymphatic and blood flow, and modulating nociceptive input via stimulation of cutaneous mechanoreceptors. In the context of postoperative care, KT may also help reduce localized edema, support incision sites, and promote a sense of physical stability that contributes to pain relief.

Despite its growing popularity in rehabilitation and sports medicine, the use of KinesioTaping in postoperative settings-particularly in cardiothoracic surgery-remains under-investigated. Limited studies have suggested potential benefits in reducing pain and improving functional outcomes, but current evidence is inconclusive and often methodologically limited.

This prospective, randomized controlled trial aims to evaluate the effectiveness of KinesioTaping when applied around mediastinal and thoracic drain sites in patients undergoing cardiac surgery. The primary objective is to assess postoperative pain levels using validated pain scales (e.g., VAS) in patients receiving KT versus those receiving standard care without taping. Secondary outcomes include opioid consumption, time to ambulation, respiratory function (spirometry or incentive spirometry use), incidence of atelectasis, and patient satisfaction scores.

By providing high-quality evidence on a low-cost, non-invasive, and easily applicable intervention, this study seeks to clarify the potential role of KinesioTaping as an adjunctive tool in postoperative pain management protocols following cardiac surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Condition: Pain, Postoperative Associated Conditions: Cardiac Surgical Procedures, Thoracic Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kinesiotaping group

In this group, KinesioTaping will be applied alongside routine pain management.

Group Type EXPERIMENTAL

Kinesiotaping

Intervention Type OTHER

In this group, KinesioTaping will be applied around the thoracic drain sites alongside standard analgesic therapy. This physical therapy technique uses elastic tapes placed on the skin to support healing, reduce pain, and improve patient comfort. The tapes will remain in place for 2-3 days and will be removed together with the drains.

Routine treatment group

This group will be managed with standard hospital-based painkiller administration.

Group Type ACTIVE_COMPARATOR

Dexketoprofen, tramadol

Intervention Type DRUG

Patients in this group will be treated with painkillers consisting of tramadol and dexketoprofen.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesiotaping

In this group, KinesioTaping will be applied around the thoracic drain sites alongside standard analgesic therapy. This physical therapy technique uses elastic tapes placed on the skin to support healing, reduce pain, and improve patient comfort. The tapes will remain in place for 2-3 days and will be removed together with the drains.

Intervention Type OTHER

Dexketoprofen, tramadol

Patients in this group will be treated with painkillers consisting of tramadol and dexketoprofen.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Kinesiotape

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective cardiac surgery cases
* Patients who are stable until the removal of the chest drain
* Patients who do not experience serious complications such as bleeding or neurological problems

Exclusion Criteria

* Patients undergoing emergency cardiac surgery,
* Patients with early post-cardiac surgery mortality,
* Patients with conditions requiring reoperation, such as bleeding,
* Patients for whom a pain score cannot be measured, such as neurological complications
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kastamonu University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

İsmail DAL

Assistant Professor Literally: Doctor Teaching Member

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kastamonu Education and Research Hospital

Kastamonu, Kastamonu, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KastamonuUnii

Identifier Type: -

Identifier Source: org_study_id